SIGLEC15 and cancer: The AKR1C1+ inflammatory fibroblast interacts with CTSK+ macrophages (CD44:SIGLEC15), which are known to induce cancer progression and metastasis in multiple cancer types35 (Fig. 4D and Supplementary Fig. S12D).